Next 10 |
home / stock / seovf / seovf news
--News Direct-- Dr. Daniel Mahony to step down to pursue new commitment LONDON, Ontario; BOSTON, Massachusetts – April 22, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the develop...
(TheNewswire) Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and ...
2024-03-27 17:08:02 ET © 2020 www.B-TV.com . All Rights Reserved. Regenerative medicine solution that could be used for diabetes and other chronic diseases Sernova is a regenerative medicine therapeutics company. They are developing therapeutics platform technologies ...
2024-03-27 17:08:02 ET A new approach to treating chronic diseases Sernova is a regenerative medicine therapeutics company. They're developing therapeutics platform technologies to treat chronic diseases through a regenerative medicine approach. The company's primary focus is the ...
2024-03-27 17:08:02 ET A new approach to treating chronic diseases including Type 1 Diabetes Sernova is developing therapeutics platform technologies to treat chronic diseases through a regenerative medicine approach. Further, the company's primary focus is the development of ...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - March 11, 2024 – Sernova Corp. (TSX:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage company focused on providing regenerative medicine therapeutics to patients with chronic conditions, today announ...
2024-01-29 07:21:15 ET More on Sernova Historical earnings data for Sernova Financial information for Sernova Read the full article on Seeking Alpha For further details see: Sernova reports anticipated 2024 milestones
(TheNewswire) Recently completed recruitment of all 7 patients in Cohort 2 Anticipates additional data from Cohort 2 of Phase 1/2 clinical trial evaluating its enhanced 10-channel Cell Pouch in patients with type 1 diabetes (T1D) in Q1/24 Expects to report precli...
Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...
2023-11-27 15:06:31 ET More on Sernova Historical earnings data for Sernova Financial information for Sernova For further details see: Sernova gets FDA orphan drug, rare pediatric designations for hemophilia A
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Dr. Daniel Mahony to step down to pursue new commitment LONDON, Ontario; BOSTON, Massachusetts – April 22, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the develop...
(TheNewswire) Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and ...
2024-03-27 17:08:02 ET © 2020 www.B-TV.com . All Rights Reserved. Regenerative medicine solution that could be used for diabetes and other chronic diseases Sernova is a regenerative medicine therapeutics company. They are developing therapeutics platform technologies ...